<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2004-10-11" modified="2020-10-07" version="170">
<accession>P67775</accession>
<accession>P05323</accession>
<accession>P13197</accession>
<name>PP2AA_HUMAN</name>
<protein>
<recommendedName>
<fullName>Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform</fullName>
<shortName>PP2A-alpha</shortName>
<ecNumber evidence="16 23 24">3.1.3.16</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Replication protein C</fullName>
<shortName>RP-C</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">PPP2CA</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1988" name="Nucleic Acids Res." volume="16" first="11365" last="11365">
<title>The nucleotide sequence of the cDNA encoding the human lung protein phosphatase 2A alpha catalytic subunit.</title>
<authorList>
<person name="Stone S.R."/>
<person name="Mayer R."/>
<person name="Wernet W."/>
<person name="Maurer F."/>
<person name="Hofsteenge J."/>
<person name="Hemmings B.A."/>
</authorList>
<dbReference type="PubMed" id="2849764"/>
<dbReference type="DOI" id="10.1093/nar/16.23.11365"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Fibroblast</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1988" name="Proc. Natl. Acad. Sci. U.S.A." volume="85" first="4252" last="4256">
<title>Human liver phosphatase 2A: cDNA and amino acid sequence of two catalytic subunit isotypes.</title>
<authorList>
<person name="Arino J."/>
<person name="Woon C.W."/>
<person name="Brautigan D.L."/>
<person name="Miller T.B. Jr."/>
<person name="Johnson G.L."/>
</authorList>
<dbReference type="PubMed" id="2837763"/>
<dbReference type="DOI" id="10.1073/pnas.85.12.4252"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1991" name="Biochemistry" volume="30" first="89" last="97">
<title>Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes.</title>
<authorList>
<person name="Khew-Goodall Y."/>
<person name="Mayer R.E."/>
<person name="Maurer F."/>
<person name="Stone S.R."/>
<person name="Hemmings B.A."/>
</authorList>
<dbReference type="PubMed" id="1846293"/>
<dbReference type="DOI" id="10.1021/bi00215a014"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Lung</tissue>
<tissue>Placenta</tissue>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1991" name="Mol. Cell. Biol." volume="11" first="1996" last="2003">
<title>Dephosphorylation of simian virus 40 large-T antigen and p53 protein by protein phosphatase 2A: inhibition by small-t antigen.</title>
<authorList>
<person name="Scheidtmann K.H."/>
<person name="Mumby M.C."/>
<person name="Rundell K."/>
<person name="Walter G."/>
</authorList>
<dbReference type="PubMed" id="1848668"/>
<dbReference type="DOI" id="10.1128/mcb.11.4.1996"/>
</citation>
<scope>DEPHOSPHORYLATION OF SV40 LARGE-T ANTIGEN AND P53 PROTEIN</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="16311" last="16317">
<title>The catalytic subunit of protein phosphatase 2A is carboxyl-methylated in vivo.</title>
<authorList>
<person name="Favre B."/>
<person name="Zolnierowicz S."/>
<person name="Turowski P."/>
<person name="Hemmings B.A."/>
</authorList>
<dbReference type="PubMed" id="8206937"/>
</citation>
<scope>METHYLATION AT LEU-309</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1998" name="Biochem. Biophys. Res. Commun." volume="247" first="827" last="832">
<title>Alpha 4 associates with protein phosphatases 2A, 4, and 6.</title>
<authorList>
<person name="Chen J."/>
<person name="Peterson R.T."/>
<person name="Schreiber S.L."/>
</authorList>
<dbReference type="PubMed" id="9647778"/>
<dbReference type="DOI" id="10.1006/bbrc.1998.8792"/>
</citation>
<scope>INTERACTION WITH IGBP1</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1999" name="Biochem. J." volume="339" first="241" last="246">
<title>Methylated C-terminal leucine residue of PP2A catalytic subunit is important for binding of regulatory Balpha subunit.</title>
<authorList>
<person name="Bryant J.C."/>
<person name="Westphal R.S."/>
<person name="Wadzinski B.E."/>
</authorList>
<dbReference type="PubMed" id="10191253"/>
<dbReference type="DOI" id="10.1042/bj3390241"/>
</citation>
<scope>MUTAGENESIS OF LEU-309</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1989" name="EMBO J." volume="8" first="3891" last="3898">
<title>Activation of SV40 DNA replication in vitro by cellular protein phosphatase 2A.</title>
<authorList>
<person name="Virshup D.M."/>
<person name="Kauffman M.G."/>
<person name="Kelly T.J."/>
</authorList>
<dbReference type="PubMed" id="2555176"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1989.tb08568.x"/>
</citation>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>ACTIVATION OF SV40 REPLICATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="3439" last="3445">
<title>Identification of a domain of Axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain.</title>
<authorList>
<person name="Hsu W."/>
<person name="Zeng L."/>
<person name="Costantini F."/>
</authorList>
<dbReference type="PubMed" id="9920888"/>
<dbReference type="DOI" id="10.1074/jbc.274.6.3439"/>
</citation>
<scope>INTERACTION WITH AXIN1</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="22300" last="22304">
<title>Raf-1-associated protein phosphatase 2A as a positive regulator of kinase activation.</title>
<authorList>
<person name="Abraham D."/>
<person name="Podar K."/>
<person name="Pacher M."/>
<person name="Kubicek M."/>
<person name="Welzel N."/>
<person name="Hemmings B.A."/>
<person name="Dilworth S.M."/>
<person name="Mischak H."/>
<person name="Kolch W."/>
<person name="Baccarini M."/>
</authorList>
<dbReference type="PubMed" id="10801873"/>
<dbReference type="DOI" id="10.1074/jbc.m003259200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RAF1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2006" name="Dev. Cell" volume="10" first="575" last="585">
<title>PP2A is required for centromeric localization of Sgo1 and proper chromosome segregation.</title>
<authorList>
<person name="Tang Z."/>
<person name="Shu H."/>
<person name="Qi W."/>
<person name="Mahmood N.A."/>
<person name="Mumby M.C."/>
<person name="Yu H."/>
</authorList>
<dbReference type="PubMed" id="16580887"/>
<dbReference type="DOI" id="10.1016/j.devcel.2006.03.010"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>INTERACTION WITH SGO1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="Mol. Pharmacol." volume="69" first="608" last="617">
<title>A direct interaction between the N terminus of adenylyl cyclase AC8 and the catalytic subunit of protein phosphatase 2A.</title>
<authorList>
<person name="Crossthwaite A.J."/>
<person name="Ciruela A."/>
<person name="Rayner T.F."/>
<person name="Cooper D.M."/>
</authorList>
<dbReference type="PubMed" id="16258073"/>
<dbReference type="DOI" id="10.1124/mol.105.018275"/>
</citation>
<scope>INTERACTION WITH ADCY8</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Nature" volume="441" first="46" last="52">
<title>Shugoshin collaborates with protein phosphatase 2A to protect cohesin.</title>
<authorList>
<person name="Kitajima T.S."/>
<person name="Sakuno T."/>
<person name="Ishiguro K."/>
<person name="Iemura S."/>
<person name="Natsume T."/>
<person name="Kawashima S.A."/>
<person name="Watanabe Y."/>
</authorList>
<dbReference type="PubMed" id="16541025"/>
<dbReference type="DOI" id="10.1038/nature04663"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH SGO1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="4800" last="4805">
<title>Protein phosphatase 2A regulates the stability of Pim protein kinases.</title>
<authorList>
<person name="Losman J.A."/>
<person name="Chen X.P."/>
<person name="Vuong B.Q."/>
<person name="Fay S."/>
<person name="Rothman P.B."/>
</authorList>
<dbReference type="PubMed" id="12473674"/>
<dbReference type="DOI" id="10.1074/jbc.m208246200"/>
</citation>
<scope>INTERACTION WITH PIM3</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2007" name="EMBO J." volume="26" first="402" last="411">
<title>A specific PP2A regulatory subunit, B56gamma, mediates DNA damage-induced dephosphorylation of p53 at Thr55.</title>
<authorList>
<person name="Li H.H."/>
<person name="Cai X."/>
<person name="Shouse G.P."/>
<person name="Piluso L.G."/>
<person name="Liu X."/>
</authorList>
<dbReference type="PubMed" id="17245430"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601519"/>
</citation>
<scope>INTERACTION WITH TP53</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="J. Cell Biol." volume="177" first="413" last="424">
<title>Tripin/hSgo2 recruits MCAK to the inner centromere to correct defective kinetochore attachments.</title>
<authorList>
<person name="Huang H."/>
<person name="Feng J."/>
<person name="Famulski J."/>
<person name="Rattner J.B."/>
<person name="Liu S.T."/>
<person name="Kao G.D."/>
<person name="Muschel R."/>
<person name="Chan G.K."/>
<person name="Yen T.J."/>
</authorList>
<dbReference type="PubMed" id="17485487"/>
<dbReference type="DOI" id="10.1083/jcb.200701122"/>
</citation>
<scope>INTERACTION WITH SGO2</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Mol. Cell" volume="36" first="51" last="60">
<title>Alpha4 is an essential regulator of PP2A phosphatase activity.</title>
<authorList>
<person name="Kong M."/>
<person name="Ditsworth D."/>
<person name="Lindsten T."/>
<person name="Thompson C.B."/>
</authorList>
<dbReference type="PubMed" id="19818709"/>
<dbReference type="DOI" id="10.1016/j.molcel.2009.09.025"/>
</citation>
<scope>INTERACTION WITH IGBP1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2010" name="Biochemistry" volume="49" first="1713" last="1718">
<title>Alpha4 is a ubiquitin-binding protein that regulates protein serine/threonine phosphatase 2A ubiquitination.</title>
<authorList>
<person name="McConnell J.L."/>
<person name="Watkins G.R."/>
<person name="Soss S.E."/>
<person name="Franz H.S."/>
<person name="McCorvey L.R."/>
<person name="Spiller B.W."/>
<person name="Chazin W.J."/>
<person name="Wadzinski B.E."/>
</authorList>
<dbReference type="PubMed" id="20092282"/>
<dbReference type="DOI" id="10.1021/bi901837h"/>
</citation>
<scope>INTERACTION WITH IGBP1</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="2485" last="2490">
<title>Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.</title>
<authorList>
<person name="Xie D."/>
<person name="Gore C."/>
<person name="Liu J."/>
<person name="Pong R.C."/>
<person name="Mason R."/>
<person name="Hao G."/>
<person name="Long M."/>
<person name="Kabbani W."/>
<person name="Yu L."/>
<person name="Zhang H."/>
<person name="Chen H."/>
<person name="Sun X."/>
<person name="Boothman D.A."/>
<person name="Min W."/>
<person name="Hsieh J.T."/>
</authorList>
<dbReference type="PubMed" id="20080667"/>
<dbReference type="DOI" id="10.1073/pnas.0908133107"/>
</citation>
<scope>INTERACTION WITH GSK3B</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="4853" last="4862">
<title>Identification and characterization of an alternatively spliced isoform of the human protein phosphatase 2Aalpha catalytic subunit.</title>
<authorList>
<person name="Migueleti D.L."/>
<person name="Smetana J.H."/>
<person name="Nunes H.F."/>
<person name="Kobarg J."/>
<person name="Zanchin N.I."/>
</authorList>
<dbReference type="PubMed" id="22167190"/>
<dbReference type="DOI" id="10.1074/jbc.m111.283341"/>
</citation>
<scope>ALTERNATIVE SPLICING (ISOFORM 2)</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="24207" last="24215">
<title>Monoubiquitination promotes calpain cleavage of the protein phosphatase 2A (PP2A) regulatory subunit alpha4, altering PP2A stability and microtubule-associated protein phosphorylation.</title>
<authorList>
<person name="Watkins G.R."/>
<person name="Wang N."/>
<person name="Mazalouskas M.D."/>
<person name="Gomez R.J."/>
<person name="Guthrie C.R."/>
<person name="Kraemer B.C."/>
<person name="Schweiger S."/>
<person name="Spiller B.W."/>
<person name="Wadzinski B.E."/>
</authorList>
<dbReference type="PubMed" id="22613722"/>
<dbReference type="DOI" id="10.1074/jbc.m112.368613"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2016" name="Oncotarget" volume="7" first="63887" last="63900">
<title>FAM122A, a new endogenous inhibitor of protein phosphatase 2A.</title>
<authorList>
<person name="Fan L."/>
<person name="Liu M.H."/>
<person name="Guo M."/>
<person name="Hu C.X."/>
<person name="Yan Z.W."/>
<person name="Chen J."/>
<person name="Chen G.Q."/>
<person name="Huang Y."/>
</authorList>
<dbReference type="PubMed" id="27588481"/>
<dbReference type="DOI" id="10.18632/oncotarget.11698"/>
</citation>
<scope>INTERACTION WITH FAM122A</scope>
<scope>UBIQUITINATION</scope>
<scope>PROTEASOMAL DEGRADATION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2017" name="Mol. Immunol." volume="88" first="79" last="88">
<title>MFHAS1 suppresses TLR4 signaling pathway via induction of PP2A C subunit cytoplasm translocation and inhibition of c-Jun dephosphorylation at Thr239.</title>
<authorList>
<person name="Shi Q."/>
<person name="Xiong B."/>
<person name="Zhong J."/>
<person name="Wang H."/>
<person name="Ma D."/>
<person name="Miao C."/>
</authorList>
<dbReference type="PubMed" id="28609714"/>
<dbReference type="DOI" id="10.1016/j.molimm.2017.06.017"/>
</citation>
<scope>INTERACTION WITH MFHAS1</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2018" name="IScience" volume="11" first="134" last="145">
<title>Mitogenic Signals Stimulate the CREB Coactivator CRTC3 through PP2A Recruitment.</title>
<authorList>
<person name="Sonntag T."/>
<person name="Ostojic J."/>
<person name="Vaughan J.M."/>
<person name="Moresco J.J."/>
<person name="Yoon Y.S."/>
<person name="Yates J.R. III"/>
<person name="Montminy M."/>
</authorList>
<dbReference type="PubMed" id="30611118"/>
<dbReference type="DOI" id="10.1016/j.isci.2018.12.012"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH CRTC3</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2006" name="Cell" volume="127" first="341" last="353">
<title>Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins.</title>
<authorList>
<person name="Xing Y."/>
<person name="Xu Y."/>
<person name="Chen Y."/>
<person name="Jeffrey P.D."/>
<person name="Chao Y."/>
<person name="Lin Z."/>
<person name="Li Z."/>
<person name="Strack S."/>
<person name="Stock J.B."/>
<person name="Shi Y."/>
</authorList>
<dbReference type="PubMed" id="17055435"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.025"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEX WITH MANGANESE IONS</scope>
<scope>COFACTOR</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2008" name="Cell" volume="133" first="154" last="163">
<title>Structural mechanism of demethylation and inactivation of protein phosphatase 2A.</title>
<authorList>
<person name="Xing Y."/>
<person name="Li Z."/>
<person name="Chen Y."/>
<person name="Stock J.B."/>
<person name="Jeffrey P.D."/>
<person name="Shi Y."/>
</authorList>
<dbReference type="PubMed" id="18394995"/>
<dbReference type="DOI" id="10.1016/j.cell.2008.02.041"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) IN COMPLEX WITH PPP2R1A AND PPME1</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2019" name="Am. J. Hum. Genet." volume="104" first="139" last="156">
<title>De novo mutations affecting the catalytic C alpha subunit of PP2A, PPP2CA, cause syndromic intellectual disability resembling other PP2A-related neurodevelopmental disorders.</title>
<authorList>
<person name="Reynhout S."/>
<person name="Jansen S."/>
<person name="Haesen D."/>
<person name="van Belle S."/>
<person name="de Munnik S.A."/>
<person name="Bongers E.M.H.F."/>
<person name="Schieving J.H."/>
<person name="Marcelis C."/>
<person name="Amiel J."/>
<person name="Rio M."/>
<person name="Mclaughlin H."/>
<person name="Ladda R."/>
<person name="Sell S."/>
<person name="Kriek M."/>
<person name="Peeters-Scholte C.M.P.C.D."/>
<person name="Terhal P.A."/>
<person name="van Gassen K.L."/>
<person name="Verbeek N."/>
<person name="Henry S."/>
<person name="Scott Schwoerer J."/>
<person name="Malik S."/>
<person name="Revencu N."/>
<person name="Ferreira C.R."/>
<person name="Macnamara E."/>
<person name="Braakman H.M.H."/>
<person name="Brimble E."/>
<person name="Ruzhnikov M.R.Z."/>
<person name="Wagner M."/>
<person name="Harrer P."/>
<person name="Wieczorek D."/>
<person name="Kuechler A."/>
<person name="Tziperman B."/>
<person name="Barel O."/>
<person name="de Vries B.B.A."/>
<person name="Gordon C.T."/>
<person name="Janssens V."/>
<person name="Vissers L.E.L.M."/>
</authorList>
<dbReference type="PubMed" id="30595372"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2018.12.002"/>
</citation>
<scope>INVOLVEMENT IN NEDLBA</scope>
<scope>VARIANTS NEDLBA VAL-60; GLY-88; HIS-122; 125-GLN--LEU-309 DEL; CYS-127; HIS-131; ARG-191; 214-ARG--LEU-309 DEL; HIS-223; VAL-223; CYS-265; 295-ARG--LEU-309 DEL AND PHE-308 INS</scope>
<scope>CHARACTERIZATION OF VARIANTS NEDLBA GLY-88; HIS-122; 125-GLN--LEU-309 DEL; CYS-127; HIS-131; ARG-191; 214-ARG--LEU-309 DEL; HIS-223; VAL-223; CYS-265; 295-ARG--LEU-309 DEL AND PHE-308 INS</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF ASP-85</scope>
<scope>CARBOXYMETHYLATION</scope>
<scope>INTERACTION WITH PP2A SUBUNIT A AND PP2A SUBUNITS B</scope>
</reference>
<comment type="function">
<text evidence="3 7 20 27">PP2A is the major phosphatase for microtubule-associated proteins (MAPs). PP2A can modulate the activity of phosphorylase B kinase casein kinase 2, mitogen-stimulated S6 kinase, and MAP-2 kinase. Cooperates with SGO2 to protect centromeric cohesin from separase-mediated cleavage in oocytes specifically during meiosis I (By similarity). Can dephosphorylate SV40 large T antigen and p53/TP53. Activates RAF1 by dephosphorylating it at 'Ser-259'.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="16">
<text>H2O + O-phospho-L-seryl-[protein] = L-seryl-[protein] + phosphate</text>
<dbReference type="Rhea" id="RHEA:20629"/>
<dbReference type="Rhea" id="RHEA-COMP:9863"/>
<dbReference type="Rhea" id="RHEA-COMP:11604"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:29999"/>
<dbReference type="ChEBI" id="CHEBI:43474"/>
<dbReference type="ChEBI" id="CHEBI:83421"/>
<dbReference type="EC" id="3.1.3.16"/>
</reaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="23 24">
<text>H2O + O-phospho-L-threonyl-[protein] = L-threonyl-[protein] + phosphate</text>
<dbReference type="Rhea" id="RHEA:47004"/>
<dbReference type="Rhea" id="RHEA-COMP:11060"/>
<dbReference type="Rhea" id="RHEA-COMP:11605"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:30013"/>
<dbReference type="ChEBI" id="CHEBI:43474"/>
<dbReference type="ChEBI" id="CHEBI:61977"/>
<dbReference type="EC" id="3.1.3.16"/>
</reaction>
</comment>
<comment type="cofactor">
<cofactor evidence="12">
<name>Mn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29035"/>
</cofactor>
<text evidence="12">Binds 2 manganese ions per subunit.</text>
</comment>
<comment type="subunit">
<text evidence="3 4 7 8 9 10 11 12 13 14 15 17 18 19 21 22 23 24 26 27">PP2A consists of a common heterodimeric core enzyme, composed of PPP2CA a 36 kDa catalytic subunit (subunit C) and PPP2R1A a 65 kDa constant regulatory subunit (PR65 or subunit A), that associates with a variety of regulatory subunits. Proteins that associate with the core dimer include three families of regulatory subunits B (the R2/B/PR55/B55, R3/B''/PR72/PR130/PR59 and R5/B'/B56 families), the 48 kDa variable regulatory subunit, viral proteins, and cell signaling molecules (PubMed:18394995, PubMed:30595372). Interacts with NXN; the interaction is direct (By similarity). Interacts with KCTD20 (By similarity). Interacts with BTBD10 (By similarity). Interacts with SGO1 and SGO2 (PubMed:16580887, PubMed:16541025, PubMed:17485487). Interacts with TP53 (PubMed:17245430). Interacts with AXIN1; the interaction dephosphorylates AXIN1. Interacts with PIM3; this interaction promotes dephosphorylation, ubiquitination and proteasomal degradation of PIM3. Interacts with RAF1. Interaction with IGBP1 protects unassembled PPP2CA from degradative ubiquitination. Interacts with GSK3B (via C2 domain). Interacts with MFHAS1; retains PPP2CA into the cytoplasm and excludes it from the nucleus (PubMed:28609714). Interacts with FAM122A (PubMed:27588481). Interacts with ADCY8; interaction is phosphatase activity-dependent; antagonizes interaction between ADCY8 and calmodulin (PubMed:16258073). Interacts with CRTC3 (when phosphorylated at 'Ser-391') (PubMed:30611118).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-296087">
<id>P31749</id>
<label>AKT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-359234">
<id>P39687</id>
<label>ANP32A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-18036948">
<id>Q3SXR2</id>
<label>C3orf36</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-1056029">
<id>Q16740</id>
<label>CLPP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-73440">
<id>P06730</id>
<label>EIF4E</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-1748945">
<id>P46695</id>
<label>IER3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-1055954">
<id>P78318</id>
<label>IGBP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>17</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-81266">
<id>O14920</id>
<label>IKBKB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
<label>IKBKG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-8481408">
<id>Q969F8</id>
<label>KISS1R</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-11985629">
<id>Q96JM7-2</id>
<label>L3MBTL3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-302388">
<id>P30153</id>
<label>PPP2R1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>43</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-357094">
<id>P30154</id>
<label>PPP2R1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-1774058">
<id>Q9Y2T4</id>
<label>PPP2R2C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-641666">
<id>Q15172</id>
<label>PPP2R5A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-1369497">
<id>Q15173</id>
<label>PPP2R5B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-1266156">
<id>Q13362</id>
<label>PPP2R5C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-365996">
<id>P04049</id>
<label>RAF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-971402">
<id>P28749</id>
<label>RBL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-971439">
<id>Q08999</id>
<label>RBL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-73886">
<id>Q04206</id>
<label>RELA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-989069">
<id>Q5FBB7</id>
<label>SGO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-1773588">
<id>Q5VSL9</id>
<label>STRIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-1046642">
<id>O43815</id>
<label>STRN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-1054735">
<id>O75663</id>
<label>TIPRL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-17716262">
<id>Q9UPQ4-2</id>
<label>TRIM35</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-358993">
<id>Q15645</id>
<label>TRIP13</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-2514383">
<id>Q5T6F2</id>
<label>UBAP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-2107455">
<id>Q08AM6</id>
<label>VAC14</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-866453">
<id>P03129</id>
<label>E7</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-7005254">
<id>P04020</id>
<label>E7</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-7002233">
<id>Q61249</id>
<label>Igbp1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712311">
<id>P67775</id>
</interactant>
<interactant intactId="EBI-309684">
<id>P97346</id>
<label>Nxn</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-16765970">
<id>P67775-1</id>
</interactant>
<interactant intactId="EBI-1772895">
<id>Q9Y570</id>
<label>PPME1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-16765970">
<id>P67775-1</id>
</interactant>
<interactant intactId="EBI-1054735">
<id>O75663</id>
<label>TIPRL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-16766021">
<id>P67775-2</id>
</interactant>
<interactant intactId="EBI-1054735">
<id>O75663</id>
<label>TIPRL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="10">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="10">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="10">Chromosome</location>
<location evidence="10">Centromere</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="10">Cytoplasm</location>
<location evidence="10">Cytoskeleton</location>
<location evidence="10">Spindle pole</location>
</subcellularLocation>
<text evidence="3">In prometaphase cells, but not in anaphase cells, localizes at centromeres. During mitosis, also found at spindle poles. Centromeric localization requires the presence of SGO2 (By similarity).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P67775-1</id>
<name>1</name>
<name>PP2Acalpha1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P67775-2</id>
<name>2</name>
<name>PP2Acalpha2</name>
<sequence type="described" ref="VSP_044320"/>
</isoform>
</comment>
<comment type="PTM">
<text evidence="25">Reversibly methyl esterified on Leu-309 by leucine carboxyl methyltransferase 1 (LCMT1) and protein phosphatase methylesterase 1 (PPME1). Carboxyl methylation influences the affinity of the catalytic subunit for the different regulatory subunits, thereby modulating the PP2A holoenzyme's substrate specificity, enzyme activity and cellular localization.</text>
</comment>
<comment type="PTM">
<text>Phosphorylation of either threonine (by autophosphorylation-activated protein kinase) or tyrosine results in inactivation of the phosphatase. Auto-dephosphorylation has been suggested as a mechanism for reactivation.</text>
</comment>
<comment type="PTM">
<text evidence="21">Polyubiquitinated, leading to its degradation by the proteasome.</text>
</comment>
<comment type="disease" evidence="23">
<disease id="DI-05507">
<name>Neurodevelopmental disorder and language delay with or without structural brain abnormalities</name>
<acronym>NEDLBA</acronym>
<description>An autosomal dominant neurodevelopmental disorder characterized by global developmental delay with onset in infancy and additional variable features including hypotonia, epilepsy, brain abnormalities such as ventriculomegaly and a small corpus callosum, and autism spectrum disorder.</description>
<dbReference type="MIM" id="618354"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 2</molecule>
<text evidence="28">Catalytically inactive, shows enhanced binding to IGBP1, and does not interact with the scaffolding subunit PPP2R1A.</text>
</comment>
<comment type="similarity">
<text evidence="28">Belongs to the PPP phosphatase family. PP-1 subfamily.</text>
</comment>
<dbReference type="EC" id="3.1.3.16" evidence="16 23 24"/>
<dbReference type="EMBL" id="X12646">
<property type="protein sequence ID" value="CAA31176.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="J03804">
<property type="protein sequence ID" value="AAB38019.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M60483">
<property type="protein sequence ID" value="AAA36466.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC000400">
<property type="protein sequence ID" value="AAH00400.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC002657">
<property type="protein sequence ID" value="AAH02657.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC019275">
<property type="protein sequence ID" value="AAH19275.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC031696">
<property type="protein sequence ID" value="AAH31696.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4173.1">
<molecule id="P67775-1"/>
</dbReference>
<dbReference type="PIR" id="S01986">
<property type="entry name" value="PAHU2A"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002706.1">
<molecule id="P67775-1"/>
<property type="nucleotide sequence ID" value="NM_002715.2"/>
</dbReference>
<dbReference type="PDB" id="2IAE">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="C/F=1-309"/>
</dbReference>
<dbReference type="PDB" id="2IE3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="C=1-309"/>
</dbReference>
<dbReference type="PDB" id="2IE4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="C=1-309"/>
</dbReference>
<dbReference type="PDB" id="2NPP">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="C/F=1-309"/>
</dbReference>
<dbReference type="PDB" id="2NYL">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.80"/>
<property type="chains" value="C/F=2-294"/>
</dbReference>
<dbReference type="PDB" id="2NYM">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.60"/>
<property type="chains" value="C/F=2-294"/>
</dbReference>
<dbReference type="PDB" id="3C5W">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="C=1-309"/>
</dbReference>
<dbReference type="PDB" id="3DW8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="C/F=1-309"/>
</dbReference>
<dbReference type="PDB" id="3FGA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="C=1-309"/>
</dbReference>
<dbReference type="PDB" id="3K7V">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="C=1-309"/>
</dbReference>
<dbReference type="PDB" id="3K7W">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.96"/>
<property type="chains" value="C=1-309"/>
</dbReference>
<dbReference type="PDB" id="3P71">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="C=1-309"/>
</dbReference>
<dbReference type="PDB" id="4I5L">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.43"/>
<property type="chains" value="C/F=1-309"/>
</dbReference>
<dbReference type="PDB" id="4I5N">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="C/F=1-309"/>
</dbReference>
<dbReference type="PDB" id="4IYP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="C=6-153"/>
</dbReference>
<dbReference type="PDB" id="4LAC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.82"/>
<property type="chains" value="C=1-309"/>
</dbReference>
<dbReference type="PDB" id="5W0W">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.80"/>
<property type="chains" value="C/F/I/L=1-309"/>
</dbReference>
<dbReference type="PDB" id="6NTS">
<property type="method" value="EM"/>
<property type="resolution" value="3.63"/>
<property type="chains" value="C=1-301"/>
</dbReference>
<dbReference type="PDBsum" id="2IAE"/>
<dbReference type="PDBsum" id="2IE3"/>
<dbReference type="PDBsum" id="2IE4"/>
<dbReference type="PDBsum" id="2NPP"/>
<dbReference type="PDBsum" id="2NYL"/>
<dbReference type="PDBsum" id="2NYM"/>
<dbReference type="PDBsum" id="3C5W"/>
<dbReference type="PDBsum" id="3DW8"/>
<dbReference type="PDBsum" id="3FGA"/>
<dbReference type="PDBsum" id="3K7V"/>
<dbReference type="PDBsum" id="3K7W"/>
<dbReference type="PDBsum" id="3P71"/>
<dbReference type="PDBsum" id="4I5L"/>
<dbReference type="PDBsum" id="4I5N"/>
<dbReference type="PDBsum" id="4IYP"/>
<dbReference type="PDBsum" id="4LAC"/>
<dbReference type="PDBsum" id="5W0W"/>
<dbReference type="PDBsum" id="6NTS"/>
<dbReference type="SMR" id="P67775"/>
<dbReference type="BioGRID" id="111507">
<property type="interactions" value="335"/>
</dbReference>
<dbReference type="CORUM" id="P67775"/>
<dbReference type="DIP" id="DIP-29395N"/>
<dbReference type="IntAct" id="P67775">
<property type="interactions" value="204"/>
</dbReference>
<dbReference type="MINT" id="P67775"/>
<dbReference type="STRING" id="9606.ENSP00000418447"/>
<dbReference type="BindingDB" id="P67775"/>
<dbReference type="ChEMBL" id="CHEMBL4703"/>
<dbReference type="DrugBank" id="DB06905">
<property type="generic name" value="(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB02506">
<property type="generic name" value="2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB14001">
<property type="generic name" value="alpha-Tocopherol succinate"/>
</dbReference>
<dbReference type="DrugBank" id="DB14002">
<property type="generic name" value="D-alpha-Tocopherol acetate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00163">
<property type="generic name" value="Vitamin E"/>
</dbReference>
<dbReference type="DEPOD" id="PPP2CA"/>
<dbReference type="iPTMnet" id="P67775"/>
<dbReference type="PhosphoSitePlus" id="P67775"/>
<dbReference type="SwissPalm" id="P67775"/>
<dbReference type="BioMuta" id="PPP2CA"/>
<dbReference type="DMDM" id="54038809"/>
<dbReference type="EPD" id="P67775"/>
<dbReference type="jPOST" id="P67775"/>
<dbReference type="MassIVE" id="P67775"/>
<dbReference type="MaxQB" id="P67775"/>
<dbReference type="PaxDb" id="P67775"/>
<dbReference type="PeptideAtlas" id="P67775"/>
<dbReference type="PRIDE" id="P67775"/>
<dbReference type="ProteomicsDB" id="57521">
<molecule id="P67775-1"/>
</dbReference>
<dbReference type="Antibodypedia" id="3550">
<property type="antibodies" value="635 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="5515"/>
<dbReference type="Ensembl" id="ENST00000481195">
<molecule id="P67775-1"/>
<property type="protein sequence ID" value="ENSP00000418447"/>
<property type="gene ID" value="ENSG00000113575"/>
</dbReference>
<dbReference type="GeneID" id="5515"/>
<dbReference type="KEGG" id="hsa:5515"/>
<dbReference type="UCSC" id="uc003kze.4">
<molecule id="P67775-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5515"/>
<dbReference type="DisGeNET" id="5515"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000113575.9"/>
<dbReference type="GeneCards" id="PPP2CA"/>
<dbReference type="HGNC" id="HGNC:9299">
<property type="gene designation" value="PPP2CA"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000113575">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="PPP2CA"/>
<dbReference type="MIM" id="176915">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="618354">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P67775"/>
<dbReference type="OpenTargets" id="ENSG00000113575"/>
<dbReference type="PharmGKB" id="PA33663"/>
<dbReference type="eggNOG" id="KOG0371">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00550000074618"/>
<dbReference type="HOGENOM" id="CLU_004962_0_5_1"/>
<dbReference type="InParanoid" id="P67775"/>
<dbReference type="KO" id="K04382"/>
<dbReference type="OMA" id="MKVRYPN"/>
<dbReference type="PhylomeDB" id="P67775"/>
<dbReference type="TreeFam" id="TF105559"/>
<dbReference type="BioCyc" id="MetaCyc:HS03696-MONOMER"/>
<dbReference type="PathwayCommons" id="P67775"/>
<dbReference type="Reactome" id="R-HSA-113501">
<property type="pathway name" value="Inhibition of replication initiation of damaged DNA by RB1/E2F1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1295596">
<property type="pathway name" value="Spry regulation of FGF signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-141444">
<property type="pathway name" value="Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-163685">
<property type="pathway name" value="Integration of energy metabolism"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-163767">
<property type="pathway name" value="PP2A-mediated dephosphorylation of key metabolic factors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-180024">
<property type="pathway name" value="DARPP-32 events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-195253">
<property type="pathway name" value="Degradation of beta-catenin by the destruction complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-196299">
<property type="pathway name" value="Beta-catenin phosphorylation cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-198753">
<property type="pathway name" value="ERK/MAPK targets"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202670">
<property type="pathway name" value="ERKs are inactivated"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2465910">
<property type="pathway name" value="MASTL Facilitates Mitotic Progression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2467813">
<property type="pathway name" value="Separation of Sister Chromatids"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2500257">
<property type="pathway name" value="Resolution of Sister Chromatid Cohesion"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2995383">
<property type="pathway name" value="Initiation of Nuclear Envelope (NE) Reformation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-389513">
<property type="pathway name" value="CTLA4 inhibitory signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-432142">
<property type="pathway name" value="Platelet sensitization by LDL"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4641262">
<property type="pathway name" value="Disassembly of the destruction complex and recruitment of AXIN to the membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5339716">
<property type="pathway name" value="Misspliced GSK3beta mutants stabilize beta-catenin"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5358747">
<property type="pathway name" value="S33 mutants of beta-catenin aren't phosphorylated"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5358749">
<property type="pathway name" value="S37 mutants of beta-catenin aren't phosphorylated"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5358751">
<property type="pathway name" value="S45 mutants of beta-catenin aren't phosphorylated"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5358752">
<property type="pathway name" value="T41 mutants of beta-catenin aren't phosphorylated"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5467337">
<property type="pathway name" value="APC truncation mutants have impaired AXIN binding"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5467340">
<property type="pathway name" value="AXIN missense mutants destabilize the destruction complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5467348">
<property type="pathway name" value="Truncations of AMER1 destabilize the destruction complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5663220">
<property type="pathway name" value="RHO GTPases Activate Formins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673000">
<property type="pathway name" value="RAF activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5675221">
<property type="pathway name" value="Negative regulation of MAPK pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804757">
<property type="pathway name" value="Regulation of TP53 Degradation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-68877">
<property type="pathway name" value="Mitotic Prometaphase"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69231">
<property type="pathway name" value="Cyclin D associated events in G1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69273">
<property type="pathway name" value="Cyclin A/B1/B2 associated events during G2/M transition"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9634600">
<property type="pathway name" value="Regulation of glycolysis by fructose 2,6-bisphosphate metabolism"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9648025">
<property type="pathway name" value="EML4 and NUDC in mitotic spindle formation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975957">
<property type="pathway name" value="Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)"/>
</dbReference>
<dbReference type="SignaLink" id="P67775"/>
<dbReference type="SIGNOR" id="P67775"/>
<dbReference type="BioGRID-ORCS" id="5515">
<property type="hits" value="539 hits in 885 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="PPP2CA">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P67775"/>
<dbReference type="GeneWiki" id="PPP2CA"/>
<dbReference type="GenomeRNAi" id="5515"/>
<dbReference type="Pharos" id="P67775">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:P67775"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="RNAct" id="P67775">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000113575">
<property type="expression patterns" value="Expressed in frontal cortex and 246 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P67775">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P67775">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0000775">
<property type="term" value="C:chromosome, centromeric region"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015630">
<property type="term" value="C:microtubule cytoskeleton"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000159">
<property type="term" value="C:protein phosphatase type 2A complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000922">
<property type="term" value="C:spindle pole"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0050811">
<property type="term" value="F:GABA receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004721">
<property type="term" value="F:phosphoprotein phosphatase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004722">
<property type="term" value="F:protein serine/threonine phosphatase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048156">
<property type="term" value="F:tau protein binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006672">
<property type="term" value="P:ceramide metabolic process"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000188">
<property type="term" value="P:inactivation of MAPK activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051321">
<property type="term" value="P:meiotic cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007498">
<property type="term" value="P:mesoderm development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007084">
<property type="term" value="P:mitotic nuclear envelope reassembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030308">
<property type="term" value="P:negative regulation of cell growth"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010719">
<property type="term" value="P:negative regulation of epithelial to mesenchymal transition"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042532">
<property type="term" value="P:negative regulation of tyrosine phosphorylation of STAT protein"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000184">
<property type="term" value="P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070262">
<property type="term" value="P:peptidyl-serine dephosphorylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035970">
<property type="term" value="P:peptidyl-threonine dephosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904528">
<property type="term" value="P:positive regulation of microtubule binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071902">
<property type="term" value="P:positive regulation of protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006470">
<property type="term" value="P:protein dephosphorylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030155">
<property type="term" value="P:regulation of cell adhesion"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045595">
<property type="term" value="P:regulation of cell differentiation"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006275">
<property type="term" value="P:regulation of DNA replication"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0040008">
<property type="term" value="P:regulation of growth"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904526">
<property type="term" value="P:regulation of microtubule binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001932">
<property type="term" value="P:regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030111">
<property type="term" value="P:regulation of Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010288">
<property type="term" value="P:response to lead ion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010033">
<property type="term" value="P:response to organic substance"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008380">
<property type="term" value="P:RNA splicing"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019932">
<property type="term" value="P:second-messenger-mediated signaling"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="3.60.21.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR004843">
<property type="entry name" value="Calcineurin-like_PHP_ApaH"/>
</dbReference>
<dbReference type="InterPro" id="IPR029052">
<property type="entry name" value="Metallo-depent_PP-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR006186">
<property type="entry name" value="Ser/Thr-sp_prot-phosphatase"/>
</dbReference>
<dbReference type="Pfam" id="PF00149">
<property type="entry name" value="Metallophos"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00114">
<property type="entry name" value="STPHPHTASE"/>
</dbReference>
<dbReference type="SMART" id="SM00156">
<property type="entry name" value="PP2Ac"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00125">
<property type="entry name" value="SER_THR_PHOSPHATASE"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0137">Centromere</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0464">Manganese</keyword>
<keyword id="KW-0469">Meiosis</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0904">Protein phosphatase</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform" id="PRO_0000058839">
<location>
<begin position="1"/>
<end position="309"/>
</location>
</feature>
<feature type="active site" description="Proton donor" evidence="3">
<location>
<position position="118"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Manganese 1" evidence="12">
<location>
<position position="57"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Manganese 1" evidence="12">
<location>
<position position="59"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Manganese 1" evidence="12">
<location>
<position position="85"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Manganese 2" evidence="12">
<location>
<position position="85"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Manganese 2" evidence="12">
<location>
<position position="117"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Manganese 2" evidence="12">
<location>
<position position="167"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Manganese 2" evidence="12">
<location>
<position position="241"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="5">
<location>
<position position="307"/>
</location>
</feature>
<feature type="modified residue" description="Leucine methyl ester" evidence="25">
<location>
<position position="309"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_044320" evidence="28">
<location>
<begin position="193"/>
<end position="246"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11552681." id="VAR_051735">
<original>V</original>
<variation>A</variation>
<location>
<position position="52"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDLBA; unknown pathological significance." id="VAR_082064" evidence="23">
<original>G</original>
<variation>V</variation>
<location>
<position position="60"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDLBA; loss of phosphatase activity in an in vitro assay; strong decrease in C-terminal methylation; decreased interaction with PP2A subunit A PPP2R1A/PPP2R1B; loss of interaction with PP2A subunit B component PPP2R2A; decreased interaction with PP2A subunit B components PPP2R5A, PPP2R5B, PPP2R5E, PPP2R3A and STRN3; dbSNP:rs1561737008." id="VAR_082065" evidence="23">
<original>D</original>
<variation>G</variation>
<location>
<position position="88"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDLBA; decreased phosphatase activity in an in vitro assay; no effect on the interaction with PP2A subunit A PPP2R1A/PPP2R1B; increased interaction with PP2A subunit B component STRN3; no effect on interaction with other PP2A subunit B components." id="VAR_082066" evidence="23">
<original>Q</original>
<variation>H</variation>
<location>
<position position="122"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDLBA; may be expressed at very low levels, if any." id="VAR_082067" evidence="23">
<location>
<begin position="125"/>
<end position="309"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDLBA; almost complete loss of phosphatase activity in an in vitro assay; strong decrease in C-terminal methylation; no effect on the interaction with PP2A subunit A PPP2R1A/PPP2R1B; decreased interaction with PP2A subunit B components PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E and PPP2R3A; no effect on interaction with PP2A subunit B component PPP2R2A." id="VAR_082068" evidence="23">
<original>Y</original>
<variation>C</variation>
<location>
<position position="127"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDLBA; increased phosphatase activity in an in vitro assay; no effect on C-terminal methylation; decreased interaction with PP2A subunit A PPP2R1A/PPP2R1B; loss of interaction with PP2A subunit B components PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D and PPP2R5E; no effect on interaction with PP2A subunit B components PPP2R2A and PPP2R3A." id="VAR_082069" evidence="23">
<original>D</original>
<variation>H</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDLBA; decreased phosphatase activity in an in vitro assay; no effect on the interaction with PP2A subunit A PPP2R1A/PPP2R1B; decreased interaction with PP2A subunit B component PPP2R5D; increased interaction with PP2A subunit B component STRN3; no effect on interaction with other PP2A subunit B components; dbSNP:rs915349596." id="VAR_082070" evidence="23">
<original>H</original>
<variation>R</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDLBA; loss of phosphatase activity in an in vitro assay; complete loss of interaction with PP2A subunit A PPP2R1A/PPP2R1B; interacts with alpha4/IGBP1; loss of interaction with PP2A subunit B components; dbSNP:rs148071386." id="VAR_082071" evidence="23">
<location>
<begin position="214"/>
<end position="309"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDLBA; decreased phosphatase activity in an in vitro assay; no effect on C-terminal methylation; no effect on the interaction with PP2A subunit A PPP2R1A/PPP2R1B; no effect on interaction with PP2A subunit B components." id="VAR_082072" evidence="23">
<original>D</original>
<variation>H</variation>
<location>
<position position="223"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDLBA; no effect on phosphatase activity in an in vitro assay; no effect on the interaction with PP2A subunit A PPP2R1A/PPP2R1B; no effect on interaction with PP2A subunit B components." id="VAR_082073" evidence="23">
<original>D</original>
<variation>V</variation>
<location>
<position position="223"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDLBA; severe decrease in phosphatase activity in an in vitro assay; strong decrease in C-terminal methylation; decreased interaction with PP2A subunit A PPP2R1A/PPP2R1B; loss of interaction with PP2A subunit B components PPP2R2A, PPP2R5A, PPP2R5B, PPP2R5E, PPP2R3A and STRN3; decreased interaction with PP2A subunit B components PPP2R5C and PPP2R5D; dbSNP:rs1561733474." id="VAR_082074" evidence="23">
<original>Y</original>
<variation>C</variation>
<location>
<position position="265"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDLBA; almost complete loss of phosphatase activity in an in vitro assay; decreased interaction with PP2A subunit A PPP2R1A/PPP2R1B; strongly decreased interaction with PP2A subunit B components PPP2R2A and PPP2R3A; increased interaction with PP2A subunit B component STRN3; no effect on interaction with PP2A subunit B components PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D and PPP2R5E." id="VAR_082075" evidence="23">
<original>F</original>
<variation>FF</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphatase activity." evidence="23">
<original>D</original>
<variation>N</variation>
<location>
<position position="85"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of binding to PP2A B-alpha regulatory subunit." evidence="6">
<original>L</original>
<variation>A</variation>
<location>
<position position="309"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="3"/>
<end position="18"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="25"/>
<end position="39"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="44"/>
<end position="48"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="50"/>
<end position="55"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="62"/>
<end position="72"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="75"/>
<end position="77"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="80"/>
<end position="82"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="87"/>
<end position="91"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="93"/>
<end position="106"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="108"/>
<end position="110"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="111"/>
<end position="113"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="121"/>
<end position="127"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="129"/>
<end position="137"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="138"/>
<end position="140"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="141"/>
<end position="150"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="155"/>
<end position="159"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="160"/>
<end position="162"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="163"/>
<end position="168"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="177"/>
<end position="182"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="186"/>
<end position="188"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="191"/>
<end position="193"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="194"/>
<end position="200"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="205"/>
<end position="211"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="215"/>
<end position="220"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="222"/>
<end position="232"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="235"/>
<end position="239"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="247"/>
<end position="251"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="252"/>
<end position="255"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="256"/>
<end position="259"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="265"/>
<end position="267"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="273"/>
<end position="278"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="284"/>
<end position="289"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3C5W"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4I5L"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P63330"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P67774"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10191253"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10801873"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12473674"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16258073"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16541025"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16580887"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17055435"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17245430"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17485487"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18394995"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1848668"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19818709"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20080667"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20092282"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22613722"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27588481"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28609714"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30595372"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30611118"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8206937"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9647778"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9920888"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000305"/>
<sequence length="309" mass="35594" checksum="C602291F78F34555" modified="2004-10-11" version="1">MDEKVFTKELDQWIEQLNECKQLSESQVKSLCEKAKEILTKESNVQEVRCPVTVCGDVHGQFHDLMELFRIGGKSPDTNYLFMGDYVDRGYYSVETVTLLVALKVRYRERITILRGNHESRQITQVYGFYDECLRKYGNANVWKYFTDLFDYLPLTALVDGQIFCLHGGLSPSIDTLDHIRALDRLQEVPHEGPMCDLLWSDPDDRGGWGISPRGAGYTFGQDISETFNHANGLTLVSRAHQLVMEGYNWCHDRNVVTIFSAPNYCYRCGNQAAIMELDDTLKYSFLQFDPAPRRGEPHVTRRTPDYFL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

